Orbimed Advisors Llc - Insider Trading & Ownership

Entity
Company
Location
601 Lexington Avenue, 54 Th Floor, New York, NY
Summary
The estimated value of insider holdings of Orbimed Advisors Llc is at least $960M dollars as of September 23, 2024. Orbimed Advisors Llc is the 10%+ Owner of SpringWorks Therapeutics, Inc. and owns shares of SpringWorks Therapeutics, Inc. (SWTX) stock worth about $233M. Orbimed Advisors Llc is the Director, 10%+ Owner of Edgewise Therapeutics, Inc. and owns shares of Edgewise Therapeutics, Inc. (EWTX) stock worth about $228M. Orbimed Advisors Llc is the Director, 10%+ Owner of Enliven Therapeutics, Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $170M. Orbimed Advisors Llc is the Director of Verona Pharma plc and owns shares of Verona Pharma plc (VRNA) stock worth about $75.6M. Orbimed Advisors Llc is the Director, 10%+ Owner of Third Harmonic Bio, Inc. and owns shares of Third Harmonic Bio, Inc. (THRD) stock worth about $59.5M. Orbimed Advisors Llc is the 10%+ Owner of NeuroPace Inc and owns shares of NeuroPace Inc (NPCE) stock worth about $47.8M. Orbimed Advisors Llc is the Director, 10%+ Owner of Prelude Therapeutics Inc and owns shares of Prelude Therapeutics Inc (PRLD) stock worth about $38.2M. Orbimed Advisors Llc is the Director, 10%+ Owner of Compass Therapeutics, Inc. and owns shares of Compass Therapeutics, Inc. (CMPX) stock worth about $29.4M. Orbimed Advisors Llc is the 10%+ Owner of 89bio, Inc. and owns shares of 89bio, Inc. (ETNB) stock worth about $21.1M. Orbimed Advisors Llc is the 10%+ Owner of TELA Bio, Inc. and owns shares of TELA Bio, Inc. (TELA) stock worth about $10.9M. Orbimed Advisors Llc is the Director of Disc Medicine, Inc. and owns shares of Disc Medicine, Inc. (IRON) stock worth about $8.47M. Orbimed Advisors Llc is the Director, 10%+ Owner of Terns Pharmaceuticals, Inc. and owns shares of Terns Pharmaceuticals, Inc. (TERN) stock worth about $7.56M. Orbimed Advisors Llc is the 10%+ Owner of Passage BIO, Inc. and owns shares of Passage BIO, Inc. (PASG) stock worth about $5.53M. Orbimed Advisors Llc is the Director, 10%+ Owner of ArriVent Biopharma, Inc. and owns shares of ArriVent BioPharma, Inc. (AVBP) stock worth about $5.52M. Orbimed Advisors Llc is the Director of Keros Therapeutics, Inc. and owns shares of Keros Therapeutics, Inc. (KROS) stock worth about $5.26M. Orbimed Advisors Llc is the Director, 10%+ Owner of Adicet Bio, Inc. and owns shares of Adicet Bio, Inc. (ACET) stock worth about $3.01M. Orbimed Advisors Llc is the Director, 10%+ Owner of Acutus Medical, Inc. and owns shares of Acutus Medical, Inc. (AFIB) stock worth about $2.62M. Orbimed Advisors Llc is the Director, 10%+ Owner of Corvus Pharmaceuticals, Inc. and owns shares of Corvus Pharmaceuticals, Inc. (CRVS) stock worth about $2.5M. Orbimed Advisors Llc is the 10%+ Owner of Arcutis Biotherapeutics, Inc. and owns shares of Arcutis Biotherapeutics, Inc. (ARQT) stock worth about $1.47M. Orbimed Advisors Llc is the Director of Janux Therapeutics, Inc. and owns shares of Janux Therapeutics, Inc. (JANX) stock worth about $1.36M. Orbimed Advisors Llc is the Director, 10%+ Owner of Homology Medicines, Inc. and owns shares of Q32 Bio Inc. (QTTB) stock worth about $1.29M. Orbimed Advisors Llc is the 10%+ Owner of Galecto, Inc. and owns shares of Galecto, Inc. (GLTO) stock worth about $1.13M. Orbimed Advisors Llc is the 10%+ Owner of scPharmaceuticals Inc. and owns shares of scPharmaceuticals Inc. (SCPH) stock worth about $1.01M. Orbimed Advisors Llc is the Director of Ikena Oncology, Inc. and owns shares of Ikena Oncology, Inc. (IKNA) stock worth about $489K. Orbimed Advisors Llc is the 10%+ Owner of Traws Pharma, Inc. and owns shares of Traws Pharma, Inc. (TRAW) stock worth about $283K. Orbimed Advisors Llc is the Director of Repare Therapeutics Inc. and owns shares of Repare Therapeutics Inc. (RPTX) stock worth about $233K. Orbimed Advisors Llc is the Director, 10%+ Owner of Xtant Medical Holdings, Inc. and owns shares of Xtant Medical Holdings, Inc. (XTNT) stock worth about $131K.
All Insider Reports
All Insider Reports

Ownership of Orbimed Advisors Llc

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SWTX SpringWorks Therapeutics, Inc. 10%+ Owner $233M Sep 12, 2022
EWTX Edgewise Therapeutics, Inc. Director, 10%+ Owner $228M +$5M +2.24% Jan 23, 2024
ELVN Enliven Therapeutics, Inc. Director, 10%+ Owner $170M -$22.9M -11.9% May 16, 2024
VRNA Verona Pharma plc Director $75.6M May 11, 2023
THRD Third Harmonic Bio, Inc. Director, 10%+ Owner $59.5M Sep 19, 2022
NPCE NeuroPace Inc 10%+ Owner $47.8M -$8.61M -15.3% May 1, 2024
PRLD Prelude Therapeutics Inc Director, 10%+ Owner $38.2M May 22, 2023
CMPX Compass Therapeutics, Inc. Director, 10%+ Owner $29.4M Nov 8, 2022
ETNB 89bio, Inc. 10%+ Owner $21.1M Jan 25, 2022
TELA TELA Bio, Inc. 10%+ Owner $10.9M -$2.02M -15.6% Jun 28, 2024
IRON Disc Medicine, Inc. Director $8.47M -$29.6M -77.7% Jun 17, 2024
TERN Terns Pharmaceuticals, Inc. Director, 10%+ Owner $7.56M -$562K -6.92% Jul 15, 2024
PASG Passage BIO, Inc. 10%+ Owner $5.53M -$175K -3.06% Sep 19, 2024
AVBP ArriVent BioPharma, Inc. Director, 10%+ Owner $5.52M Jan 30, 2024
KROS Keros Therapeutics, Inc. Director $5.26M -$11M -67.7% Aug 13, 2024
ACET Adicet Bio, Inc. Director, 10%+ Owner $3.01M +$7.5M Jan 25, 2024
AFIB Acutus Medical, Inc. Director, 10%+ Owner $2.62M Jul 19, 2021
CRVS Corvus Pharmaceuticals, Inc. Director, 10%+ Owner $2.5M +$2.5M May 6, 2024
ARQT Arcutis Biotherapeutics, Inc. 10%+ Owner $1.47M Jun 24, 2022
JANX Janux Therapeutics, Inc. Director $1.36M Dec 29, 2021
QTTB Q32 Bio Inc. Director, 10%+ Owner $1.29M Mar 25, 2024
GLTO Galecto, Inc. 10%+ Owner $1.13M Aug 15, 2023
SCPH scPharmaceuticals Inc. 10%+ Owner $1.01M +$2M Aug 13, 2024
IKNA Ikena Oncology, Inc. Director $489K Aug 4, 2023
TRAW Traws Pharma, Inc. 10%+ Owner $283K Sep 16, 2024
RPTX Repare Therapeutics Inc. Director $233K Sep 3, 2021
XTNT Xtant Medical Holdings, Inc. Director, 10%+ Owner $131K Aug 15, 2022
ALPN ALPINE IMMUNE SCIENCES, INC. Director $0 -$28.7M -100% May 18, 2024
SPRY ARS Pharmaceuticals, Inc. Director $0 -$12.6M -100% Aug 26, 2024
KNTE Kinnate Biopharma Inc. Director, 10%+ Owner $0 Apr 3, 2024
THRX Theseus Pharmaceuticals, Inc. Director, 10%+ Owner $0 Feb 14, 2024
MBX MBX Biosciences, Inc. Director, 10%+ Owner Sep 16, 2024
PMVP PMV Pharmaceuticals, Inc. 10%+ Owner -$196K Nov 22, 2023
SRRA Sierra Oncology, Inc. Director, 10%+ Owner Jul 1, 2022
TCDA Tricida, Inc. Director, 10%+ Owner Nov 22, 2022
TSBX Turnstone Biologics Corp. Director, 10%+ Owner Jul 20, 2023

Insider Transactions Reported by Orbimed Advisors Llc:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.